A novel epidermal growth factor receptor inhibitor for treating lung cancer
To investigate the effects of a novel synthetic epidermal growth factor receptor inhibitor, COMPOUND7809, on the inhibition of lung cancer growth in vitro and the underlying mechanisms, we treated three lung tumor cell lines (A549, SK-LU-1, and NCI-H23) with COMPOUND7809 and a Food and Drug Administ...
Saved in:
Main Authors: | Jiansheng Gao, Yuli Liang, Dongying Zhang, Yi Wang, Jiamin Yang, Hua Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-03-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317698358 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor–tyrosine kinase inhibitors
by: Huang-Chih Chang, et al.
Published: (2017-03-01) -
EGFRp4 Peptides: A Novel Strategy for Epidermal Growth Factor Receptor (EGFR) Inhibitor
by: Nattanan Jiwacharoenchai, et al.
Published: (2025-06-01) -
Antitumor effect of a new human epidermal growth factor receptor inhibitor
by: O. I. Kit, et al.
Published: (2024-09-01) -
Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
by: Shaohua Cui, et al.
Published: (2017-04-01) -
Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
by: O.M. Smorodska, et al.
Published: (2021-06-01)